Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma

In recent years, tumor immunotherapy has become an important treatment program and popular research focus. However, the use of immune checkpoint inhibitors (ICI) in the treatment of colorectal cancer still has limitations due to the current markers only being able to predict the prognosis of a small...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Anqi, Xu, Wentao, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551610/
https://www.ncbi.nlm.nih.gov/pubmed/34721019
http://dx.doi.org/10.3389/fphar.2021.721181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551610/
https://www.ncbi.nlm.nih.gov/pubmed/34721019
http://dx.doi.org/10.3389/fphar.2021.721181

Ejemplares similares